Are you in the United States?

Switch to Twig Science to check out our NGSS product.

How We See Part 1: Eyes

Curing blindness is one of the hottest areas of stem cell research because eyes are unlikely to reject transplanted tissue and with an ageing population, eyesight problems are a growing trend.

The US team behind this latest trial are already developing stem cell treatments for age-related macular degeneration, a condition affecting 30 million people worldwide.

But as with any stem cell therapy, the use of cells from human embryos is controversial.

Watch How We See Part 1: Eyes to find out more about how the eye works.